Market Place
Sourcing Support
Helsinn & Chugai sign a partnership agreement renewal to commercialize AKYNZEO
12 Jun 2024 //
GLOBENEWSWIRE
Farma Mondo Group & Helsinn sign exclusive partnership to commercialize AKYNZEO
28 Nov 2022 //
GLOBENEWSWIRE
Helsinn Group and Italfarmaco announces oral presentation of NEPA data
18 Sep 2020 //
PRESS RELEASE
Helsinn announces launch of oral formulation of Akynzeo® in China
08 Jun 2020 //
GLOBENEWSWIRE
Glenmark launches Helsinn`s Akynzeo in India
11 Jul 2018 //
BIOSPECTRUM
Glenmark expands its oncology franchise in India with launch of Akynzeo
11 Jul 2018 //
ECONOMIC TIMES
Glenmark launches FDC drug Akynzeo for chemotherapy-induced nausea and vomiting
10 Jul 2018 //
PHARMABIZ
Glenmark gets license to market Akynzeo in India
04 Apr 2018 //
THEPHARMALETTER
Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise
18 Mar 2016 //
PR NEWS WIRE
Six new therapies approved for NHS Scotland
12 Jan 2016 //
PHARMATIMES
Helsinn Group and Eisai Inc. Announce Inclusion of AKYNZEO in ASCO
13 Nov 2015 //
PR NEWS WIRE
Chugai Pharma launches netupitant-palonosetron fixed dose combo in UK
10 Sep 2015 //
PHARMABIZ
Five new drugs put forward for approval in Europe
31 Mar 2015 //
PHARMATIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.